Hépato-Gastro & Oncologie Digestive
MENUTraitement de l’endobrachyœsophage Volume 18, issue 1, Janvier-Février 2011
Figures
CHU de la Cavale-Blanche,
service d’hépatogastroentérologie, boulevard Tanguy-Prigent,
29609 Brest Cedex,
France, Institut des maladies de l’appareil digestif de Nantes,
CHU Hôtel-Dieu, service d’hépatogastroentérologie
44093 Nantes Cedex,
France
- Key words: Barrett's esophagus, dysplasia, adenocarcinoma, treatment
- DOI : 10.1684/hpg.2010.0544
- Page(s) : 76-87
- Published in: 2011
The development of therapeutic endoscopy can now offer an effective alternative to esophagectomy in Barrett patients with high-grade dysplasia or early carcinoma. Endoscopic treatment has to be complete and only lesions with a low-risk of lymph node involvement (high-grade dysplasia and intramucosal carcinomas) can be treated endoscopically with a curative intent. The risk of progression of dysplastic lesions within the Barrett's esophagus justifies the eradication of all the residual mucosa; thus, approaches combining techniques of resection of visible abnormalities and ablation techniques are currently recommended.